Redmile Group, LLC - STOKE THERAPEUTICS INC ownership

STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 65 filers reported holding STOKE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 1.4%.

Quarter-by-quarter ownership
Redmile Group, LLC ownership history of STOKE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$15,258,422
-63.7%
3,872,696
-2.1%
0.73%
-55.0%
Q2 2023$42,043,648
+21.8%
3,955,188
-4.6%
1.61%
+7.7%
Q1 2023$34,531,149
+482.3%
4,145,396
+545.3%
1.50%
+516.5%
Q4 2022$5,929,629
-44.7%
642,430
-23.1%
0.24%
-41.6%
Q3 2022$10,732,000
-59.2%
835,830
-58.1%
0.42%
-58.6%
Q2 2022$26,331,000
-38.2%
1,993,268
-1.5%
1.00%
-24.4%
Q1 2022$42,613,000
-20.9%
2,024,368
-9.9%
1.33%
+8.6%
Q4 2021$53,898,000
-11.1%
2,246,668
-5.7%
1.22%
+15.9%
Q3 2021$60,597,000
-26.8%
2,381,958
-3.1%
1.06%
-13.7%
Q2 2021$82,755,000
-16.2%
2,458,558
-3.4%
1.22%
-12.0%
Q1 2021$98,811,000
-40.6%
2,544,062
-5.3%
1.39%
-30.9%
Q4 2020$166,358,000
+94.8%
2,686,234
+5.4%
2.01%
+28.4%
Q3 2020$85,383,000
+43.2%
2,549,506
+1.9%
1.57%
+42.4%
Q2 2020$59,630,000
+20.2%
2,502,306
+15.5%
1.10%
-20.8%
Q1 2020$49,600,000
+71.6%
2,165,938
+112.2%
1.39%
+101.3%
Q4 2019$28,908,000
+32.2%
1,020,778
+0.3%
0.69%
-5.6%
Q3 2019$21,866,000
-26.6%
1,017,478
-0.4%
0.73%
-13.2%
Q2 2019$29,806,0001,021,8080.84%
Other shareholders
STOKE THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
ATP Life Science Ventures, L.P. 17,161,713$666,561,00074.20%
RTW INVESTMENTS, LP 3,644,248$141,543,0002.21%
Redmile Group, LLC 2,544,062$98,811,0001.39%
Cormorant Asset Management, LP 1,437,807$55,844,0001.24%
ACUTA CAPITAL PARTNERS, LLC 45,000$1,748,0000.63%
SPHERA FUNDS MANAGEMENT LTD. 150,729$5,854,0000.45%
HighVista Strategies LLC 13,692$532,0000.40%
Birchview Capital, LP 15,000$583,0000.35%
Perceptive Advisors 671,978$26,100,0000.33%
GILDER GAGNON HOWE & CO LLC 1,265,950$49,169,0000.26%
View complete list of STOKE THERAPEUTICS INC shareholders